Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis

Abstract

Recent evidence suggests that a substantial portion of complex disease risk alleles modify gene expression in a cell-specific manner1,2,3,4. To identify candidate causal genes and biological pathways of immune-related complex diseases, we conducted expression quantitative trait loci (eQTL) analysis on five subsets of immune cells (CD4+ T cells, CD8+ T cells, B cells, natural killer (NK) cells and monocytes) and unfractionated peripheral blood from 105 healthy Japanese volunteers. We developed a three-step analytical pipeline comprising (i) prediction of individual gene expression using our eQTL database and public epigenomic data, (ii) gene-level association analysis and (iii) prediction of cell-specific pathway activity by integrating the direction of eQTL effects. By applying this pipeline to rheumatoid arthritis data sets, we identified candidate causal genes and a cytokine pathway (upregulation of tumor necrosis factor (TNF) in CD4+ T cells). Our approach is an efficient way to characterize the polygenic contributions and potential biological mechanisms of complex diseases.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Strategy to identify the candidate causal pathways of immune-related complex diseases.
Figure 2: Upregulation of CCR2 in monocytes is a potential cause of Behçet's disease.
Figure 3: Characterization of complex traits by enrichment of immune-cell eQTL variants within their GWAS variants.
Figure 4: Dysregulation of CLECL1 isoform balance in B cells is a potential cause of multiple sclerosis.
Figure 5: Epigenomic data improved the performance of gene expression prediction.
Figure 6: Candidate causal genes and cytokine pathways in RA.

References

  1. Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).

    CAS  Article  Google Scholar 

  2. Trynka, G. et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45, 124–130 (2013).

    CAS  Article  Google Scholar 

  3. Raj, T. et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 344, 519–523 (2014).

    CAS  Article  Google Scholar 

  4. Fairfax, B.P. et al. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat. Genet. 44, 502–510 (2012).

    CAS  Article  Google Scholar 

  5. Westra, H.J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238–1243 (2013).

    CAS  Article  Google Scholar 

  6. GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015).

    Article  Google Scholar 

  7. Lappalainen, T. et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501, 506–511 (2013).

    CAS  Article  Google Scholar 

  8. Buil, A. et al. Gene-gene and gene-environment interactions detected by transcriptome sequence analysis in twins. Nat. Genet. 47, 88–91 (2015).

    CAS  Article  Google Scholar 

  9. Hettinger, J. et al. Origin of monocytes and macrophages in a committed progenitor. Nat. Immunol. 14, 821–830 (2013).

    CAS  Article  Google Scholar 

  10. Basso, K. & Dalla-Favera, R. Roles of BCL6 in normal and transformed germinal center B cells. Immunol. Rev. 247, 172–183 (2012).

    Article  Google Scholar 

  11. Tamura, A. et al. Accelerated apoptosis of peripheral blood monocytes in Cebpb-deficient mice. Biochem. Biophys. Res. Commun. 464, 654–658 (2015).

    CAS  Article  Google Scholar 

  12. Flutre, T., Wen, X., Pritchard, J. & Stephens, M. A statistical framework for joint eQTL analysis in multiple tissues. PLoS Genet. 9, e1003486 (2013).

    CAS  Article  Google Scholar 

  13. Dimas, A.S. et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 325, 1246–1250 (2009).

    CAS  Article  Google Scholar 

  14. Nica, A.C. et al. Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations. PLoS Genet. 6, e1000895 (2010).

    Article  Google Scholar 

  15. Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457–1464 (2015).

    CAS  Article  Google Scholar 

  16. Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).

    Article  Google Scholar 

  17. Kirino, Y. et al. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat. Genet. 45, 202–207 (2013).

    CAS  Article  Google Scholar 

  18. Hsieh, C.L. et al. CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury. J. Neurotrauma 31, 1677–1688 (2014).

    Article  Google Scholar 

  19. Clarkson, B.D. et al. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression. J. Immunol. 194, 531–541 (2015).

    CAS  Article  Google Scholar 

  20. Yang, J., Zhang, L., Yu, C., Yang, X.F. & Wang, H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark. Res. 2, 1 (2014).

    Article  Google Scholar 

  21. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).

    CAS  Article  Google Scholar 

  22. Kannarkat, G.T., Boss, J.M. & Tansey, M.G. The role of innate and adaptive immunity in Parkinson's disease. J. Parkinsons Dis. 3, 493–514 (2013).

    PubMed  PubMed Central  Google Scholar 

  23. Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214–219 (2011).

    CAS  Article  Google Scholar 

  24. Ryan, E.J. et al. Dendritic cell-associated lectin-1: a novel dendritic cell-associated, C-type lectin-like molecule enhances T cell secretion of IL-4. J. Immunol. 169, 5638–5648 (2002).

    CAS  Article  Google Scholar 

  25. Gamazon, E.R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091–1098 (2015).

    CAS  Article  Google Scholar 

  26. Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245–252 (2016).

    CAS  Article  Google Scholar 

  27. Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016).

    CAS  Article  Google Scholar 

  28. McInnes, I.B., Buckley, C.D. & Isaacs, J.D. Cytokines in rheumatoid arthritis—shaping the immunological landscape. Nat. Rev. Rheumatol. 12, 63–68 (2016).

    CAS  Article  Google Scholar 

  29. McInnes, I.B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429–442 (2007).

    CAS  Article  Google Scholar 

  30. Weinblatt, M.E. et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N. Engl. J. Med. 340, 253–259 (1999).

    CAS  Article  Google Scholar 

  31. Weinblatt, M.E. et al. Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study. Arthritis Rheum. 65, 28–38 (2013).

    CAS  Article  Google Scholar 

  32. Jones, G. et al. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann. Rheum. Dis. 69, 88–96 (2010).

    CAS  Article  Google Scholar 

  33. Pieper, J. et al. Peripheral and site-specific CD4+CD28null T cells from rheumatoid arthritis patients show distinct characteristics. Scand. J. Immunol. 79, 149–155 (2014).

    CAS  Article  Google Scholar 

  34. James, E.A. et al. Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy. Arthritis Rheumatol. 66, 1712–1722 (2014).

    CAS  Article  Google Scholar 

  35. Efimov, G.A. et al. Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source. Proc. Natl. Acad. Sci. USA 113, 3006–3011 (2016).

    CAS  Article  Google Scholar 

  36. Storey, J.D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440–9445 (2003).

    CAS  Article  Google Scholar 

  37. Nakamura, Y. The BioBank Japan Project. Clin. Adv. Hematol. Oncol. 5, 696–697 (2007).

    Google Scholar 

  38. Kochi, Y. et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat. Genet. 42, 515–519 (2010).

    CAS  Article  Google Scholar 

  39. Battle, A. et al. Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res. 24, 14–24 (2014).

    CAS  Article  Google Scholar 

  40. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376–381 (2014).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We would like to thank all the doctors and staff who participated in sample collection for eQTL analysis and the BioBank Japan Project and staff at the Laboratory for Genotyping Development. This research was supported by funding from Takeda pharmaceutical Co., Ltd. (Y. Kochi, K.F. and K. Yamamoto), and a grant from RIKEN (K. Ishigaki, Y. Kochi, A.S., Y.M., Y. Kamatani and M.K.). The BioBank Japan Project is supported by the Japanese Ministry of Education, Culture, Sports, Sciences and Technology.

Author information

Authors and Affiliations

Authors

Contributions

K. Ishigaki., Y. Kochi., A.S., K.F. and K. Yamamoto designed the research project. K. Ishigaki conducted bioinformatics analysis with the help of Y. Kamatani, F.M., T.T. and K. Yamaguchi. A.S., Y.M. and M.K. performed RNA sequencing. K. Ikari, A.T. and H.Y. contributed samples and data for the IORRA cohort. Y.T., H.T., S.S., Y.N., S.N., R.K., K.S. and H.S. contributed samples and data for eQTL analysis. K. Ishigaki wrote the manuscript with critical input from Y. Kochi, K.F., Y.O. and R.Y.

Corresponding author

Correspondence to Yuta Kochi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–17 and Supplementary Tables 1 and 14 (PDF 5848 kb)

Supplementary Table 2

Enrichment of cell-specific eQTL variants within transcription factor binding sites. (XLSX 125 kb)

Supplementary Table 3

List of candidate causal genes identified by combining GWAS catalog and eQTL data of each cell type. (XLSX 21945 kb)

Supplementary Table 4

List of candidate causal genes identified by combining GWAS catalog and exon-level eQTL data of each cell type. (XLSX 3917 kb)

Supplementary Table 5

List of candidate causal genes identified by combining GWAS catalog and TSS-conditioned eQTL data of each cell type. (XLSX 1376 kb)

Supplementary Table 6

Bayesian test for colocalisation between GWAS variants of RA and eQTL variants of each cell type. (XLSX 14 kb)

Supplementary Table 7

eQTL variants and their effect sizes used to predict gene expression of CD4+ T cells. (XLSX 3086 kb)

Supplementary Table 8

eQTL variants and their effect sizes used to predict gene expression of CD8+ T cells. (XLSX 3034 kb)

Supplementary Table 9

eQTL variants and their effect sizes used to predict gene expression of B cells. (XLSX 4168 kb)

Supplementary Table 10

eQTL variants and their effect sizes used to predict gene expression of NK cells. (XLSX 3605 kb)

Supplementary Table 11

eQTL variants and their effect sizes used to predict gene expression of monocytes. (XLSX 5041 kb)

Supplementary Table 12

eQTL variants and their effect sizes used to predict gene expression of PB. (XLSX 4484 kb)

Supplementary Table 13

Genes with Bonferroni significance in the case-control analysis using predicted gene expression. (XLSX 13 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ishigaki, K., Kochi, Y., Suzuki, A. et al. Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis. Nat Genet 49, 1120–1125 (2017). https://doi.org/10.1038/ng.3885

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.3885

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing